Articles
ESMH regularly publishes articles on topics related to science and new technologies that provoke a lot of media attention and that are important in the European context. Most importantly, the articles are written with the help of science writers in journalistic style and always provide the opinion of one or more scientists on the topic. The publications are accompanied by a selection of links to related information and with a focus on European research and knowledge in the field.
-
Interview with Philipp Schmid on science denialism, misinformation & the importance of public confidence in the safety & effectiveness of the Covid-19 vaccine
Dr. Philipp Schmid is a scientific researcher at the Department of Psychology at the University of Erfurt (Germany). Philipp’s research aims at analysing the psychological reasons of science denialism. He is the lead author of the WHO guideline on how to respond to vocal vaccine denier in public and... -
What drives public trust? Broadening the traditional scope of science communication with TRESCA
The COVID-19 pandemic has accelerated the digitalisation of our daily lives and, by now, we are all a bit more dependent on technology than we had been before. But how can we trust all the scientific information that we receive through the media? How can we have a common understanding of what is reliable...
-
The (digital) future of work in the post-Covid-19 era
The coronavirus pandemic has accelerated digitalization and the adoption of new technologies that are having a profound effect on the way we work. It has highlighted the urgent need to protect workers’ rights and to adopt measures that ensure inclusive growth and close the digital divide.
-
Vaccination policy in times of Covid-19
As multiple COVID-19 vaccines are emerging, what can be done to tackle vaccination hesitancy and ensure rapid and equitable deployment?
-
COVID-19: ensuring a safe and effective vaccine
Scientists around the world are working hard to come up with a COVID-19 vaccine to suppress the pandemic. How can the EU guarantee that rapidly approved vaccines are safe and effective? We asked senior representatives from the European Medicines Agency (EMA) and the European Centre for Disease Prevention...
-
Tocilizumab : a treatment alternative in COVID-19 pneumonia
Patients with severe COVID-19 pneumonia often need to be mechanically intubated and have an increased mortality risk. Tocilizumab, a drug used against the cytokine storm underlying this clinical condition, has shown positive effects in clinical trials.
-
The key role of antivirals in COVID-19 treatment (remdesivir)
A few weeks after the SARS-CoV-2 was identified by Chinese researchers as the cause of ‘COVID-19’, an antiviral called remdesivir, originally used during the 2014 Ebola outbreak, came into play as the first available option to treat patients with coronavirus disease 2019 (COVID-19). Even if the approval...
-
The potential of digital well-being in times of physical social distancing
Digital well-being tools hold the promise of empowering users to regain control of time spent online. How successful are these tools during the Covid-19 global pandemic?